Skip to main content
. 2023 Nov 22;6(4):805–827. doi: 10.20517/cdr.2023.77

Figure 4.

Figure 4

(A) Schematic illustration of the formation of pH-sensitive nanosystems (Ac-α-CD NP); (B) The cell viability of MDA-MB-231 cells treated with different doses of PTX, PLGA NP, and Ac-α-CD NP (**P < 0.01). This figure is quoted with permission from He et al.[74]; (C) Schematic illustration of the antitumor progress of Ac-α-CD NP in MCF-7/ADR cells; (D) The P-gp expression level; and (E) the accumulation of DOX with different doses of Ac-α-CD NP in MCF-7/ADR cells (*P < 0.05, **P < 0.01). This figure is quoted with permission from Shi et al.[75]. CD: Cyclodextrin; DOX: doxorubicin; NP: nanoparticle; PTX: paclitaxel.